Determinants of COVID-19 vaccine fatigue
There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be
a major obstacle in maintaining immunity in the general population. In this study, we …
a major obstacle in maintaining immunity in the general population. In this study, we …
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
S Xu, J Li, H Wang, F Wang, Z Yin, Z Wang - BMC medicine, 2023 - Springer
Background The two inactivated SARS-CoV-2 vaccines, CoronaVac and BBIBP-CorV, have
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
GE Hartley, HA Fryer, PA Gill, I Boo, SJ Bornheimer… - npj Vaccines, 2024 - nature.com
Booster vaccinations are recommended to improve protection against severe disease from
SARS-CoV-2 infection. With primary vaccinations involving various adenoviral vector and …
SARS-CoV-2 infection. With primary vaccinations involving various adenoviral vector and …
[HTML][HTML] The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
Introduction This study examines the efficacy and safety of three COVID-19 booster vaccines
including mRNA-based vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 …
including mRNA-based vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 …
Efficacy of six different SARS-coV-2 vaccines during a six-month follow-up and five COVID-19 waves in Brazil and Mexico
ME Romero-Ibarguengoitia, D Rivera-Salinas, R Sarti… - Vaccines, 2023 - mdpi.com
Comparisons among the different vaccines against SARS-CoV-2 are important to
understand which type of vaccine provides more protection. This study aimed to evaluate the …
understand which type of vaccine provides more protection. This study aimed to evaluate the …
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
COVID-19 vaccines have been effective in preventing severe illness, hospitalization and
death, however, the effectiveness diminishes with time. Here, we evaluated the longevity of …
death, however, the effectiveness diminishes with time. Here, we evaluated the longevity of …
Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus …
GE Hartley, HA Fryer, PA Gill, I Boo, SJ Bornheimer… - bioRxiv, 2023 - biorxiv.org
Background Booster vaccinations are recommended to improve protection against severe
disease from SARS-CoV-2 infection. With primary vaccinations involving various adenoviral …
disease from SARS-CoV-2 infection. With primary vaccinations involving various adenoviral …
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
J Hollister, C Porter, R Sprissler, SC Beitel, JK Romine… - PloS one, 2024 - journals.plos.org
The extent to which semi-quantitative antibody levels confer protection against SARS-CoV-2
infection in populations with heterogenous immune histories is unclear. Two nested case …
infection in populations with heterogenous immune histories is unclear. Two nested case …
Clinical advancements in mRNA vaccines against viral infections
M Fatima, PG Park, KJ Hong - Clinical Immunology, 2024 - Elsevier
Over the last decade, mRNA vaccines development has shown significant advancement,
particularly during the COVID-19 pandemic. This comprehensive review examines the …
particularly during the COVID-19 pandemic. This comprehensive review examines the …
[HTML][HTML] Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
Background: Vaccination has played a crucial role in mitigating the spread of COVID-19 and
reducing its severe outcomes. While over 90% of Bangladesh's population has received at …
reducing its severe outcomes. While over 90% of Bangladesh's population has received at …